Objective: Antipsychotic drug efficacy may have decreased over recent decades. The
authors present a meta-analysis of all placebo-controlled trials in patients with acute …

Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

Antipsychotics are the drugs prescribed to treat psychotic disorders; however, patients often
fail to adhere to their treatment, and this has a severe negative effect on prognosis in these …

Purpose: A number of potential determinants of medication non-adherence have been
described so far. However, the heterogenic quality of existing publications poses the need …

Purpose The introduction of imatinib, a tyrosine kinase inhibitor (TKI), has greatly increased
survival for patients with chronic myeloid leukemia (CML). Conversely, nonadherence to …

Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …

The full benefit of many effective medications will be achieved only if patients adhere to
prescribed treatment regimens. Unfortunately, applying terms such as “noncompliant” and …

The availability of long-acting injectable (LAI) antipsychotics for the treatment of
schizophrenia provides clinicians with options that deliver continuous drug exposure and …

Objective: Data on the effectiveness of antipsychotics in the early phase of schizophrenia
are limited. The authors examined the risk of rehospitalization and drug discontinuation in a …